Larry Wood - 14 Jun 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
14 Jun 2021
Transactions value $
-$506,705
Form type
4
Filing time
14 Jun 2021, 21:21:39 UTC
Previous filing
19 May 2021
Next filing
12 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $276K +7.83K +2.1% $35.20 380K 14 Jun 2021 Direct F1
transaction EW Common Stock Sale -$782K -7.83K -2.06% $99.91 372K 14 Jun 2021 Direct F1
holding EW Common Stock 496 14 Jun 2021 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7.83K -14.29% $0.00 47K 14 Jun 2021 Common Stock 7.83K $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.
F2 Reflects shares represented on the most recent statement of the Issuer's 401(k) Plan Administrator.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.